RESPIRATORY
Pioneering products for respiratory testing and vaccination.
At SSI Diagnostica Group, we deliver exceptional products and expertise in the respiratory diagnostics field. Our legacy in Pneumococcus serotyping dates back to the 1930’s when we were part of the renowned Danish Statens Serum Institut. Our involvement in vaccine development began over 40 years ago by supplying antisera for quality control to a global vaccine manufacturer during the development of a pneumococcal vaccine.
Over the years, we have expanded our portfolio to address a broader range of respiratory infectious diseases, including influenza, tuberculosis, and pneumonia.
With the addition of CTK Biotech to the SSI Diagnostica Group, we strengthened our capabilities further, introducing a comprehensive range of COVID-19 diagnostic tests – both rapid and PCR – to support the fight against the global pandemic.
Bacterial
Streptococcus pneumoniae (Pneumococcus)
Streptococcus portfolio (GBS and S. suis)
Streptococcus pyogenes
Tuberculosis – Mycobacterium turberculosis
Legionella
Viral
Influenza testing
RSV – Respiratory Syncytial Virus
COVID-19 – SARS-CoV-2
Complete control of our products
We are experts in the diseases that we help detect, and are extremely conscious about which diseases we are involved with to ensure that we only invest in areas where our unique heritage and capabilities provide us with a competitive advantage. And for most of our products, we own the entire supply chain from raw materials and development to production and sales, ensuring complete control
Get in touch
If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.
Please fill in the form and we will get back to you as soon as possible.
Simpler for the better
If you work within the field of microbiology, you might be familiar with Occam’s Razor. At SSI Diagnostica, we champion a slightly adapted version of this principle:The simplest solution is usually the best one.
